Brokerage firms like Goldman Sachs have a buy rating on Power Grid and NTPC, while Macquarie has an outperform rating on BEL. UBS has downgraded Dabur to neutral from buy. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Goldman Sachs on Power Grid: Buy | Target price: … Read more
Brokerage Macquarie maintained an outperform rating on Aurobindo Pharma, Morgan Stanley initiated coverage on Suzlon, CLSA upgraded Apollo Hospital and CLSA maintained a buy rating on Titan Company. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on Aurobindo Pharma: Outperform | Target Rs 1,385Macquarie maintained an … Read more
Shares of Apollo Hospitals rallied 3.4% in Friday’s early trade to the day’s high of Rs 5,955 after the company reported a 77% year-on-year (YoY) jump in its net profit. The company’s revenue from operations in the January-March 2024 period increased 15% YoY to Rs 4,944 crore and the board of directors have also recommended … Read more
We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on Zomato: Underperform| Target Rs 96Macquarie maintained an underperform rating on Zomato with a target price of Rs 96. The competitive intensity is rising. Multiple incumbent e-commerce platforms have announced renewed ambitions in Qcom. The global investment bank … Read more
Brokerage JPMorgan maintained an overweight rating on SBI and Macquarie upgraded Escorts to outperform. CLSA downgraded Sula to underperform while maintaining a sell on Asian Paints post Q4 results. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: JPMorgan on SBI: Overweight| Target Rs 1000 JPMorgan maintained an … Read more
